Thomas R. Blue

Thomas R. Blue, Ph.D.

Thomas R. Blue, Ph.D.
Thomas R. Blue, Ph.D.
Research Scientist

Ph.D., Experimental Psychology, Quantitative Psychology Minor, Texas Christian University
Phone: 410-837-3977 ext. 232
Fax: 410-752-4218
Research Interests

Dr. Blue’s research focuses on the treatment of substance use disorders and health disparities in criminal justice populations (prisoners, parolees, and probationers). While completing his degree at Texas Christian University, he worked on a NIDA funded project to test the effectiveness of a tablet-application based curriculum for reducing behavioral health risks associated with HIV and AIDS in individuals under community supervision for drug-related offenses. Currently, his research interests include the design, testing, and implementation of emerging technologies to improve the delivery of substance abuse treatment programs and reduce health disparities, specifically HIV and AIDS, within the criminal justice population. His quantitative research interests include the design and analysis of randomized controlled trials; the use of the generalized linear model, its extensions, and the analysis of such designs; and multi-level modeling.

Selected Publications
Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, O’Grady KE (2019). Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine. Addiction Science & Clinical Practice. 14(1):45. doi: 10.1186/s13722-019-0172-2. PMID:31787108.
Gordon MS, Vocci FJ, Taxman F, Fishman M, Sharma B, Blue TR, O’Grady KE (2019). A Randomized Controlled Trial of Buprenorphine for Probationers and Parolees: Bridging the Gap into Treatment. Contemporary Clinical Trials. 79:21-27. doi: 10.1016/j.cct.2019.02.009. Epub 2019 Feb 20. PMID: 30797042.
Knight DK, Blue TR, Flynn PM, Knight K (2019). The TCU Drug Screen 5: Identifying justice-involved individuals with substance use disorders. Journal of Offender Rehabilitation. 57(8): 525-537.
Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D (2019). Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap. Journal of Substance Abuse Treatment. 103:1-8. doi: 10.1016/j.jsat.2019.05.002. Epub 2019 May 9. PMID: 31229187.
Wiese AL, Blue TR, Knight DK, Knight K (2019). The validity of TCU Drug Screen 5 for identifying substance use disorders among justice-involved youth. Federal Probation. 83: 65-70.
Gordon MS, Blue TR, Couvillion K, Schwartz RP, O’Grady KE, Fitzgerald TT, Vocci FJ (2018). Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes. Drug and Alcohol Dependence. 188:232-238. doi: 10.1016/j.drugalcdep.2018.04.010. Epub 2018 May 12. PMID: 29783095.
Blue T, Pankow J, Rowan G, and Lehman W (2017). Staying safe in the community: A table computer app for improving decision-making and reducing health risk behaviors for probationers. Texas Probation. V(2), 11-17.
Lehman WEK, Pankow J, Blue TR, and Rowan GA (2016). StaySafe: A tablet computer app for helping probationers make better decisions regarding health risk behaviors. Offender Programs Report. 19 (6), 81, 90-95.